Related Articles
PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer
Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2 Corrigendum in /10.3892/ijo.2016.3487
Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC‑3 cells via an AKR1C3 mechanism
Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells
The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro